AVIR
Atea Pharmaceuticals, Inc. · Healthcare
Chief Commercial Officer John Vavricka sold $45K of Atea Pharmaceuticals, Inc.
Sold$45,420
$3.84Price
11,819Shares
−10%Stake
What AVIR did after the filing
- The stock from Mon, Feb 5 open, $4.06
- −3.0%
- S&P 500, same days
- +4.8%
Measured over 30 trading days, to the Mar 19 close.
Traded Thu, Feb 1. Filed Fri, Feb 2, 4:25 PM ET, after the close. Returns use the Feb 5 open and the Mar 19 close. Not investment advice.